The Research and Development team at Neurogene is responsible for pioneering and advancing innovative gene therapy solutions for rare neurological disorders. They collaborate with academic researchers, patient advocacy organizations, and caregivers to develop and refine therapies that target the genetic root causes of these diseases. This team drives the progression from early-stage research through preclinical and clinical development, ensuring the viability and efficacy of new treatment modalities.